Yahoo Finance Barnes Group (B) Beats on Q2 Earnings Estimate, Lags Sales
Barnes Group Inc. B is a manufacturer of precision metal parts as well as distributes industrial supplies worldwide. End-markets served include aerospace, transportation, industrial equipment, consumer products, packaging, electronics, medical devices, energy, medical/pharmaceutical, and personal care/health care industries. It currently has a $3.4 billion market capitalization.
However, this machinery company faces risks from regulatory issues in the aerospace business, unfavorable foreign currency movements and uncertain global economic conditions. Investors are eagerly waiting for the company’s latest earnings report.
The company delivered better-than-expected results in three of the last four quarters, while lagging estimate in one. Average earnings surprise was a positive 6.23%.
Barnes Group, Inc. Price, Consensus and EPS Surprise
Barnes Group, Inc. Price, Consensus and EPS Surprise | Barnes Group, Inc. Quote
Currently, Barnes Group carries a Zacks Rank #3 (Hold), but that could definitely change after the release of its upcoming earnings report. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: Barnes Group’ adjusted earnings came in at 90 cents per share in second-quarter of 2018. The bottom line result surpassed the Zacks Consensus Estimate of 75 cents per share.
Revenue: Revenues lagged. Barnes Group generated revenues of $375.3 million, below the Zacks Consensus Estimate of $385.6 million.
Key Stats to Note: For 2018, Barnes Group anticipates organic revenue growth to be within 4-5% range, favorable foreign currency movements to boost sales by 1% and acquisitions to add 1%. Total revenue is predicted to grow 5-6%. Earnings are anticipated to be within $3.18-$3.28 per share range, reflecting year-over-year growth of 10-14%. Capital expenditures is expected to be roughly within $60-$65 million.
Stock Price: Barnes Group shares were up 4.1% ahead of the report.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Barnes Group, Inc. (B) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
